Michael Jungling analyst BARCLAYS

Currently out of the existing stock ratings of Michael Jungling, 13 are a BUY (61.9%), 7 are a HOLD (33.33%), 1 are a SELL (4.76%).

Michael Jungling

Work Performance Price Targets & Ratings Chart

Analyst Michael Jungling, currently employed at BARCLAYS, carries an average stock price target met ratio of 23.33% that have a potential upside of 9.82% achieved within 139 days.

Michael Jungling’s has documented 42 price targets and ratings displayed on 6 stocks. The coverage is on Healthcare, Consumer Cyclical sectors.

Most recent stock forecast was given on FMS, Fresenius Medical Care at 24-Sep-2021.

Wall Street Analyst Michael Jungling

Analyst best performing recommendations are on SNN (SMITH & NEPHEW SNATS).
The best stock recommendation documented was for PHG (KONINKLIJKE PHILIPS NV ADR) at 4/22/2020. The price target of $48.84 was fulfilled within 261 days with a profit of $12.17 (33.19%) receiving and performance score of 1.27.

Average potential price target upside

SNN Smith & Nephew SNATS PHG Koninklijke Philips NV ADR FMS Fresenius Medical Care FSNUY Fresenius SE KGaA ADR SMMNY Siemens Healthineers AG ADR SON Sonoco Products Company

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Buy Since 08-Dec-2025

$39

14 days ago
(08-Sep-2026)

0/1 (0%)

$6 (18.18%)

Hold Since 17-Mar-2025

$30

$-0.04 (-0.13%)

$35

4 months 11 days ago
(11-May-2026)

5/6 (83.33%)

$0.9 (3.09%)

16

Buy Since 29-Jan-2025

$37.5

$7.46 (24.83%)

11 months 8 days ago
(14-Oct-2025)

2/4 (50%)

$2.24 (6.35%)

762

Buy Since 12-Mar-2025

1 years 6 months 10 days ago
(12-Mar-2025)

0/5 (0%)

$-11.32 (-45.15%)

Buy Since 11-Apr-2023

$17.57

1 years 8 months 16 days ago
(06-Jan-2025)

0/6 (0%)

$-8.69 (-33.09%)

Show more analysts

Please expand the browser size to see the chart

What Year was the first public recommendation made by Michael Jungling?

On 2019

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?